You are currently viewing abbott covid-19 lgg/lgm rapid test device
abbott covid-19 lgg/lgm rapid test device

abbott covid-19 lgg/lgm rapid test device

about the test
Introduction

coronavirus disease (COVID-19) a
Newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)1 is an infectious disease caused by
. SARS-CoV-2 is a β-coronavirus, which is an enveloped
Non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission through droplets or direct contact, and infection is estimated to have an average incubation period of 6.4 days and a basic reproduction number of 2.2 4–3.58. In patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3 The main IVD assay used for COVID-19 employs real-time reverse transcriptase-polymerase chain reaction (RT-PCR) which takes some time hours 4. The availability of a cost-effective, rapid point-of-care diagnostic test is critical to aid in the diagnosis of patients and to enable healthcare professionals to prevent further spread of the virus. Antigen tests will play a vital role in the fight against COVID-196 .

Abbott SD Bioline Hav Lgg
Abbott SD Bioline Hav Lgg

Test theory

The Panbio COVID-19 Ag Rapid Test Device consists of a membrane strip, which
immobilized anti-SARS-CoV-2 antibodies on the test line and
The LC is pre-coated with mouse monoclonal anti-chicken IgY. two types of conjugates
(Human IgG SARS-CoV-2 Ag gold conjugate (nucleocapsid
proteins ) and chicken IgY specific to the gold conjugate) on the membrane
Chromatographically move upstream and react with anti-SARS-CoV-2 antibodies and anti-SARS. coated
Mouse monoclonal anti-chicken IgY respectively. For positive results,
Human IgG specific for SARS-CoV-2 Ag gold conjugate and anti-SARS-CoV-2 antibody
Will create a test line in the result window. Neither the test line nor the control line
Appears in the result window before applying the patient sample. One
A visible control line is required to indicate that the test result is valid. Intended Use Panbio COVID-19 Ag Rapid Test Device for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasal swab samples from individuals meeting COVID-19 diagnostic and/or epidemiological criteria. It is an in vitro diagnostic rapid test for

Panbio™ COVID-19 Ag Rapid Test Device is for commercial use only
And it is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection.
The product can be used in any laboratory and non-laboratory environment.
Meets the requirements specified in the directives and local regulation.
The test provides preliminary exam results. Negative results do not prevent SARSCoV-2 infection and can be used for treatment or
cannot be used as the sole basis for other management decisions. negative diagnostic results
Observations should be combined with patient history and epidemiological information. of test
Purpose Not intended to be used as a donor screening test for SARS-CoV-2.

Antibody tests to expand testing and help healthcare workers
While molecular tests find out whether someone has the virus, antibody tests determine whether someone was previously infected.

Abbott’s SARS-CoV-2 IgG test identifies IgG antibodies, a protein that the body produces in the late stages of infection and can persist for months and possibly years after a person recovers. Abbott’s IgG antibody test will initially be available on its ARCHITECT i 1000SR and i 2000SR laboratory equipment*. More than 2,000 of these instruments are in use in US laboratories. These devices can run up to 100-200 tests per hour.

Abbott is making the test available as part of a US Food and Drug Administration (FDA) notification without the emergency use authorization (EUA) route outlined in the policy for clinical trials for coronavirus disease-2019 during a public health emergency. Is. Additionally, Abbott plans to file an EUA submission with the FDA and is planning to send the CE mark to the IVD Directive (98/79/EC) in the EU.

Abbott is significantly ramping up its manufacturing for antibody testing and expects to ship close to 1 million tests to US customers immediately this week, and 4 million tests total for April. The company is testing up to 20 million in the US in June and beyond as it expands tests to run on its new Alinity i system. Abbott will also expand its laboratory antibody tests to detect the antibody, IgM, in the near future.

 

Panbio™ COVID-19 Ag Rapid Test Device (Nasal)

41FK11 25 Tests/Kit
EUR 99
Description: The Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 is a β -coronavirus, which is an enveloped non-segmented positive-sense RNA virus 2. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have a mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2, fever was the most common symptom, followed by cough3. The main IVD assays used for COVID-19 employ real-time reverse transcriptase-polymerase chain reaction (RT-PCR) that takes a few hours 4. The availability of a cost-effective, rapid point- of-care diagnostic test is critical to enable healthcare professionals to aid in the diagnosis of patients and prevent further spread of the virus5. Antigen tests will play a critical role in the fight against COVID-19

Biocredit Covid-19 Ag Detection Kit

G61RHA20 20 test cards (pkg)
EUR 95

COVID-19 IgG/IgM Rapid Test Kit

UNCOV-20 20T/kit
EUR 155

Purified recombinant COVID-19 (isolate Wuhan-Hu-1) NP protein

nCoVNP-126V 100ug
EUR 792
Description: Purified recombinant COVID-19(isolate Wuhan-Hu-1) NP protein was expressed in HEK293 cells.

Recombinant COVID-19 (isolate Wuhan-Hu-1) S(ΔTM) protein

nCoVS-125V 100ug
EUR 792
Description: Purified recombinant COVID-19(isolate Wuhan-Hu-1) S(ΔTM) protein was expressed in HEK293 cells.

TESTO (Testosterone) ELISA test

19 96T/Box Ask for price
Description: ELISA based test for quantitative detection of O (osterone)

Novel Coronavirus COVID-19 (2019-nCoV) Real Time RT-PCR Kit

RR-0478-02 25 tests/kit
EUR 991
Description: Novel Coronavirus (2019-nCoV) Real Time RT-PCR Kit is used for the qualitative detection of a novel coronavirus, which was identified in 2019 at Wuhan City, Hubei Province, China, in upper respiratory tract specimens (nasopharyngeal extracts, deep cough sputum, etc.) and lower respiratory tract specimens (alveoli irrigation fluid, etc.) by real time PCR systems.

Anti-Trimethyl-Histone H3 (Lys79) Rabbit Monoclonal Antibody, Clone#RM157

M06819-19 100ug
EUR 468
Description: Anti-Trimethyl-Histone H3 (Lys79) Rabbit Monoclonal Antibody, Clone#RM157 tested in WB, ELISA, Multiplex, reactive to All Vertebrates

PEDF, Pigment Epithelium-derived Factor, human

RC213-19 5ug
EUR 104.38

Oncostatin M (227 a.a.), human

RC214-19 2ug
EUR 104.38

Ciliary Neurotrophic Factor, CNTF, human

RC218-19 5ug
EUR 104.38

OPG, Osteoprotegerin, human

RC219-19 50ug
EUR 169.63

IL-8, Interleukin-8, monkey

RC222-19 5ug
EUR 104.38

Oncostatin M, murine (mouse)

RC234-19 2ug
EUR 104.38

FGF-8, murine (mouse)

RC235-19 5ug
EUR 104.38

CNTF, murine (mouse)

RC238-19 5ug
EUR 104.38

IL-8, CXCL8, Interleukin-8, canine

RC242-19 5ug
EUR 104.38

Oncostatin M, rat

RC254-19 2ug
EUR 104.38

CNTF, rat

RC258-19 5ug
EUR 104.38

 

Leave a Reply